Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Tonix Pharmaceuticals Granted Fast Track Designation by FDA for Tonmya™ for Fibromyalgia
Friday, July 26, 2024Tonix Pharmaceuticals Holding Corp a fullyintegrated biopharmaceutical company with marketed products and a pipeline of development candidates today announced that the US Food and Drug Administration has granted Fast Track
European Commission Approves Pfizer’s DURVEQTIX® (fidanacogene elaparvovec), a One-Time Gene Therapy for Adults with Hemophilia B
Friday, July 26, 2024Pfizer Inc today announced that the European Commission has granted conditional marketing authorization for DURVEQTIX a gene therapy for the treatment of severe and moderately severe hemophilia B in adult patients
Sandoz launches biosimilar Pyzchiva® (ustekinumab) across Europe, to treat chronic inflammatory diseases
Friday, July 26, 2024Sandoz the global leader in generic and biosimilar medicines announces the launch of Pyzchiva ustekinumab across Europe starting today Pyzchiva developed and registered by Samsung Bioepis is the first ustekinumab biosimilar
Hoth Therapeutics Partners with LTS Therapy Systems to Accelerate Novel Alzheimer's Treatment
Thursday, July 25, 2024Hoth Therapeutics Inc a patientfocused biopharmaceutical company today announced it has signed an agreement with LTS Therapy Systems LLC to develop and manufacture the HTALZ oral film prototype
U.S. Food and Drug Administration Approves BioMarin's BRINEURA® (cerliponase alfa) for Children Under 3 Years with CLN2 Disease
Thursday, July 25, 2024BioMarin Pharmaceutical Inc today announced that the US Food and Drug Administration has approved the companys supplemental Biologics License
Novogene to Power Cancer, Rare Disease, and Environmental Research with PacBio Sequencing
Wednesday, July 24, 2024PacBio a leading developer of highquality highly accurate sequencing solutions today announced that Novogene is using its Revio longread sequencing system to expand the capabilities of its new lab in Munich
FDA Accepts Mesoblast’s Biologics License Application (BLA) for Ryoncil® in Children With Steroid-Refractory Acute Graft-Versus-Host Disease (SR-aGVHD)
Wednesday, July 24, 2024Mesoblast Limited global leader in allogeneic cellular medicines for inflammatory diseases announced that the United States Food and Drug Administration
SciSparc: MitoCareX Confirms Potential Significant Role of its Drug Target in Non-Small Cell Lung Cancer
Tuesday, July 23, 2024SciSparc Ltd a specialty clinicalstage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system announced that MitoCareX Bio Ltd
NorthStar Medical Radioisotopes and BWXT Medical Sign Supply Agreement Supporting Actinium-225 Production
Tuesday, July 23, 2024NorthStar Medical Radioisotopes LLC and BWXT Medical Ltd a subsidiary of BWX Technologies Inc today announced that they have signed a Master Services Agreement which will facilitate the production of actinium
MyMD Pharmaceuticals Announces Corporate Rebranding to New Name TNF Pharmaceuticals, Inc.
Tuesday, July 23, 2024TNF Pharmaceuticals Inc formerly MyMD Pharmaceuticals Inc a clinical stage biopharmaceutical company committed to developing novel therapies for agerelated diseases and autoimmune and inflammatory conditions
